Fresenius is currently being investigated by the FDA for failing to warn patients of potential dangers with its product, GranuFlo. A well-respected blood dialysis physician here in St. Louis, Missouri at Washington University, Dr. Coyne, has reported that 30% of his dialysis patients have a high level of bicarbone in their system. This is scary stuff. Read further information at the Legal Examiner.
If you or a loved one has been injured by GranuFlo dialysis products, please contact Lindsay Rakers.